Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Pressure BioSciences, Inc.    PBIO

News SummaryMost relevantAll newsSector newsTweets

PRESSURE BIOSCIENC : Pressure BioSciences, Inc. to Discuss Third Quarter 2008 Financial Results and Provide Business Update

share with twitter share with LinkedIn share with facebook
share via e-mail
11/14/2008 | 10:15pm CET

SOUTH EASTON, Mass., Nov. 14 /PRNewswire-FirstCall/ -- Pressure BioSciences, Inc. (Nasdaq: PBIO) today announced that the Company will host a teleconference to discuss its third quarter 2008 financial results and to provide a business update. Anyone interested may listen to the teleconference either by telephone or through a live web-cast. The teleconference and web-cast information is provided below:

Date: Monday, November 17, 2008

Time: 4:30 p.m. Eastern Standard Time (EST)

To attend this teleconference via web-cast, please go to the Company's website: www.pressurebiosciences.com

    To attend this teleconference via telephone:
    Dial-in: (800) 344-6491
    Participant code: 3034253

For those unable to participate in the live teleconference, a replay will be available approximately one hour after the call ends, and will be accessible through the Company's website.

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (PBI) is a publicly-traded company focused on the development of a novel, enabling technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions. PBI currently holds 13 US and 6 foreign patents covering multiple applications of PCT in the life sciences' field, including such areas as genomic and proteomic sample preparation, pathogen inactivation, the control of chemical reactions, immunodiagnostics, and protein purification.

    Investor Contacts:
    Richard T. Schumacher, President & CEO
    Edward H. Myles, Senior Vice President of Finance & CFO
    Pressure BioSciences, Inc.
    (T) 508-230-1828

SOURCE Pressure BioSciences, Inc.

share with twitter share with LinkedIn share with facebook
share via e-mail
11/14 PRESSURE BIOSCIENCES, INC. : Reports Third Quarter 2017 Financial Results and Pr..
11/13 PRESSURE BIOSCIENCES : Management's Discussion and Analysis of Financial Conditi..
11/13 PRESSURE BIOSCIENCES, INC. : to Discuss Third Quarter 2017 Financial Results and..
11/01 PRESSURE BIOSCIENCES : Initiates Aggressive Marketing and Sales Strategy Expecte..
10/30 HOW PRESSURE BIOSCIENCES IS REDEFINI : The Promise of New Drugs and Cures, High ..
10/26 NETWORKNEWSWIRE : Releases Exclusive Audio Interview with Pressure BioSciences I..
10/24 PRESSURE BIOSCIENCES INC : Pressure BioSciences, Inc. Discusses Market Opportuni..
10/23 PRESSURE BIOSCIENCES : PBIO) Engages NetworkNewsWire for Corporate Communication..
10/18 PRESSURE BIOSCIENCES : and Phasex Announce Strategic Collaboration Addressing Br..
10/10 PRESSURE BIOSCIENCES INC : Pressure BioSciences' Penetration in European Biophar..
More news